First Eagle Investment Management’s Calithera Biosciences, Inc CALA Stock Holding History

First Eagle Investment Management’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-21,905	Closed	-$1.42M	–	339
2016 Q4	$1.42M	Sell	21,905 -5,000	-19%	-$312K	﹤0.01%	210
2016 Q3	$1.75M	Buy	26,905 +16,637	+162%	+$1.07M	﹤0.01%	223
2016 Q2	$762K	Hold	10,268	–	–	﹤0.01%	258
2016 Q1	$1.17M	Hold	10,268	–	–	﹤0.01%	227
2015 Q4	$1.57M	Buy	+10,268	New	+$1.54M	﹤0.01%	208

Other funds holding CALA

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

First Eagle Investment Management's CALA Position: Q1 2017 in Review

First Eagle Investment Management sold out of Calithera Biosciences, Inc (CALA) in Q1 2017, closing a stake of 21,905 shares — an estimated $1.42M sold.

First Eagle Investment Management first reported a position in CALA in Q4 2015 and held it in 5 quarters. The position peaked at $1.75M in Q3 2016. 74 funds tracked by Wall St. Rank hold CALA as of Q1 2017.

First Eagle Investment Management reported no remaining Calithera Biosciences, Inc position as of Q1 2017 after selling out during the quarter.
First Eagle Investment Management sold 21,905 Calithera Biosciences, Inc shares in Q1 2017, an estimated $1.42M.
First Eagle Investment Management first reported a position in Calithera Biosciences, Inc in Q4 2015 and held it in 5 quarters.
First Eagle Investment Management's Calithera Biosciences, Inc position peaked at $1.75M in Q3 2016.
74 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2017.

Based on First Eagle Investment Management's 13F filing for Q1 2017, filed 5 May 2017.